https://adisinsight.springer.com/trials/700045662?error=cookies_not_supported&code=2f09377b-d97d-4125-bd29-22e336537877
A Randomized Blinded Evaluation of Two Doses of Stavudine (2',3'-Didehydro-2',3'-Dideoxythymidine;...
To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and
https://pubmed.ncbi.nlm.nih.gov/19043928/
Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa
This study confirms a high incidence of severe SHL in Africa, which has been shown in previous studies. Rechallenge with zidovudine in less severe cases was...
first lineantiretroviral therapyseverestavudine
https://open.bu.edu/items/28432c9b-5217-456b-928a-551570cf2a29
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in...
OBJECTIVE: We assessed the relationship between phasing out stavudine in first-line antiretroviral therapy (ART) in accordance with WHO 2010 policy and...
https://pubmed.ncbi.nlm.nih.gov/22132226/
Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral...
A total of 48,785 patients contributed 62,505 person-years of follow-up. Rate of all-cause toxicity was 7.80 (95%CI 7.59-8.03) per 100 person-years, but varied...